WebApr 6, 2024 · Get the latest news and real-time alerts from Chimerix, Inc. (CMRX) stock at Seeking Alpha. WebChimerix, Inc. (CMRX) Stock Price, News, Quote & History - Yahoo Finance Dow 30 Chimerix, Inc. (CMRX) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 1.2000 -0.0100... Find the latest Chimerix, Inc. (CMRX) stock discussion in Yahoo Finance's forum. … Chimerix, Inc. 2505 Meridian Parkway Suite 100 Durham, NC 27713 United States … Get the detailed quarterly/annual income statement for Chimerix, Inc. (CMRX). … Discover historical prices for CMRX stock on Yahoo Finance. View daily, weekly or … Find out all the key statistics for Chimerix, Inc. (CMRX), including valuation … See Chimerix, Inc. (CMRX) Environment, Social and Governance Ratings to help … See Chimerix, Inc. (CMRX) stock analyst estimates, including earnings and … Find out the direct holders, institutional holders and mutual fund holders for … Find the latest Chimerix, Inc. (CMRX) stock quote, history, news and other vital … Find the latest Chimerix, Inc. (CMRX) stock quote, history, news and other vital …
Chimerix, Inc. (CMRX) Stock Historical Prices & Data - Yahoo …
WebChimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC. WebGet the latest Chimerix Inc (CMRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. hillside hyundai service
Chimerix Stock (NASDAQ:CMRX), Quotes and News Summary
WebChimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. WebCMRX's current price/earnings ratio is 0.84, which is higher than only 0.38% of US stocks with positive earnings. With a year-over-year growth in debt of -88.9%, CHIMERIX INC's debt growth rate surpasses only 1.67% of about US stocks. As for revenue growth, note that CMRX's revenue has grown 1,609.15% over the past 12 months; that beats the ... WebMar 31, 2024 · What were Chimerix’s (NASDAQ:CMRX) revenues? A. The Actual Revenue was $1.8M, which beat the estimate of $870K. Browse earnings estimates, EPS, and revenue on all stocks. hillside house surgery bluebell lane